Full Text:   <2211>

CLC number: R543.3

On-line Access: 2011-08-02

Received: 2011-06-30

Revision Accepted: 2011-07-04

Crosschecked: 2011-06-30

Cited: 2

Clicked: 5165

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
1. Reference List
Open peer comments

Journal of Zhejiang University SCIENCE B 2011 Vol.12 No.8 P.660-667

http://doi.org/10.1631/jzus.B1101008


Association between SNP rs1800875, serum chymase and immunoglobulin E levels in patients with coronary heart disease


Author(s):  Chun-na Jin, Hong Ma, Yan Lin, Jian-an Wang, Mei-xiang Xiang

Affiliation(s):  Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China, Cardiovascular Key Lab of Zhejiang Province, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China

Corresponding email(s):   xiangmx@yahoo.com

Key Words:  Coronary heart disease, CMA1, Serum immunoglobulin E (IgE), Serum chymase


Chun-na Jin, Hong Ma, Yan Lin, Jian-an Wang, Mei-xiang Xiang. Association between SNP rs1800875, serum chymase and immunoglobulin E levels in patients with coronary heart disease[J]. Journal of Zhejiang University Science B, 2011, 12(8): 660-667.

@article{title="Association between SNP rs1800875, serum chymase and immunoglobulin E levels in patients with coronary heart disease",
author="Chun-na Jin, Hong Ma, Yan Lin, Jian-an Wang, Mei-xiang Xiang",
journal="Journal of Zhejiang University Science B",
volume="12",
number="8",
pages="660-667",
year="2011",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1101008"
}

%0 Journal Article
%T Association between SNP rs1800875, serum chymase and immunoglobulin E levels in patients with coronary heart disease
%A Chun-na Jin
%A Hong Ma
%A Yan Lin
%A Jian-an Wang
%A Mei-xiang Xiang
%J Journal of Zhejiang University SCIENCE B
%V 12
%N 8
%P 660-667
%@ 1673-1581
%D 2011
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1101008

TY - JOUR
T1 - Association between SNP rs1800875, serum chymase and immunoglobulin E levels in patients with coronary heart disease
A1 - Chun-na Jin
A1 - Hong Ma
A1 - Yan Lin
A1 - Jian-an Wang
A1 - Mei-xiang Xiang
J0 - Journal of Zhejiang University Science B
VL - 12
IS - 8
SP - 660
EP - 667
%@ 1673-1581
Y1 - 2011
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1101008


Abstract: 
Objective: The gene for mast cell chymase (CMA1) is an ideal candidate for investigating the genetic predisposition to coronary heart disease (CHD), as activated mast cells have been found to be present in a greater proportion in the shoulder region of atheroma than in normal coronary intimae. Previous studies have indicated that CMA1 promoter polymorphism rs1800875 may be involved in regulating immunoglobulin E (IgE) levels in patients with eczema, and it is associated with the progression of immunoglobulin A nephropathy. Methods: The association between single nucleotide polymorphism (SNP) rs1800875, serum chymase, and serum IgE levels was examined in 175 CHD subjects and 95 non-CHD subjects. Results: Statistical analysis indicated no significant difference in allele frequency between CHD and non-CHD. However, a significant association was found between CMA1 genotypes and total IgE levels in CHD subjects. Meanwhile, crossover analysis revealed that, in GG homozygotes, CHD risk was nearly six times higher in those with IgE (U/ml) level <2.58 (natural logarithm conversion), while no association was found with chymase level. Conclusions: Polymorphism rs1800875 of CMA1 may be associated with serum IgE level in CHD subjects, but not with chymase level in both groups. In GG homozygotes, high IgE level is a protective factor against coronary disease.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Reference

[1]Busse, W.W., Lemanske, R.F., 2001. Advances in immunology: asthma. N. Engl. J. Med., 2001(344):350-362.

[2]Criqui, M.H., Lee, E.R., Hamburger, R.N., Klauber, M.R., Coughlin, S.S., 1987. IgE and cardiovascular disease. Results from a population-based study. Am. J. Med., 82(5):964-968.

[3]Galli, S.J., Kalesnikoff, J., Grimbaldeston, M.A., Piliponsky, A.M., Williams, C.M.M., Tsai, M., 2005. Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol., 23(1):749-786.

[4]Gardemann, A., Harnami, M., Katz, N., Tillmann, H., Haberbosch, W., 2000. The chyrnase A(−1903)G gene polymorphism is not associated with the risk and extent of coronary heart disease. Atherosclerosis, 150(2):445-446.

[5]Gurish, M.F., Austen, K.F., 2001. The diverse roles of mast cells. J. Exp. Med., 194(1):F1-F6.

[6]He, H., Li, L.M., Cao, W.H., Sun, N.L., liu, M.Z., Hu, Y.H., 2004. Association between the I/D polymorphism of the ACE gene, A/B polymorphism of the chymase gene and the left ventricular hypertrophy in essential hypertension. Chin. J. Hypertens., 12(1):39-43 (in Chinese).

[7]Heikkila, H.M., Latti, S., Leskinen, M.J., Hakala, J.K., Kovanen, P.T., Lindstedt, K.A., 2008. Activated mast cells induce endothelial cell apoptosis by a combined action of chymase and tumor necrosis factor-α. Arterioscler. Thromb. Vasc. Biol., 28(2):309-314.

[8]Ihara, M., Urata, H., Kinoshita, A., Suzumiya, J., Sasaguri, M., Kikuchi, M., Ideishi, M., Arakawa, K., 1999. Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension, 33(6):1399-1405.

[9]Imada, T., Komorita, N., Kobayashi, F., Naito, K., Yoshikawa, T., Miyazaki, M., Nakamura, N., Kondo, T., 2002. Therapeutic potential of a specific chymase inhibitor in atopic dermatitis. Jpn. J. Pharmacol., 90(3):214-217.

[10]Iwanaga, T., McEuen, A., Walls, A.F., Clough, J.B., Keith, T.P., Rorke, S., Barton, S.J., Holgate, S.T., Holloway, J.W., 2004. Polymorphism of the mast cell chymase gene (CMA1) promoter region: lack of association with asthma but association with serum total immunoglobulin E levels in adult atopic dermatitis. Clin. Exp. Allergy, 34(7):1037-1042.

[11]Jeziorska, M., McCollum, C., Woolley, D.E., 1997. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. J. Pathol., 182(1):115-122.

[12]Korkmaz, M.E., Oto, A., Saraclar, Y., Oram, E., Oram, A., Ugurlu, S., Karamehmetoglu, A., Karaagaoglu, E., 1991. Levels of IgE in the serum of patients with coronary arterial disease. Int. J. Cardiol., 31(2):199-204.

[13]Liang, Y.H., Chen, X.L., Yu, Z.S., Chen, C.Y., Bi, S., Mao, L.G., Zhou, B.L., Zhang, X.N., 2009. Deletion analysis of SMN1 and NAIP genes in southern Chinese children with spinal muscular atrophy. J. Zhejiang Univ.-Sci. B, 10(1):29-34.

[14]Longley, B.J., Tyrrell, L., Ma, Y., Williams, D.A., Halaban, R., Langley, K., Lu, H.S., Schechter, N.M., 1997. Chymase cleavage of stem cell factor yields a bioactive, soluble product. PNAS, 94(17):9017-9021.

[15]Mizutani, H., Schechter, N., Lazarus, G., Black, R.A., Kupper, T.S., 1991. Rapid and specific conversion of precursor interleukin 1 β (IL-1β) to an active IL-1 species by human mast cell chymase. J. Exp. Med., 174(4):821-825.

[16]Ortlepp, J.R., Janssens, U., Bleckmann, F., Lauscher, J., Merkelbach-Bruse, S., Hanrath, P., Hoffmann, R., 2001. A chymase gene variant is associated with atherosclerosis in venous coronary artery bypass grafts. Coron. Artery Dis., 12(6):493-497.

[17]Pfeufer, A., Busjahn, A., Vergopoulos, A., Knoblauch, H., Urata, H., Osterziel, K.J., Menz, M., Wienker, T.F., Faulhaber, H.D., Steinmetz, A., et al., 1998. Chymase gene locus is not associated with myocardial infarction and is not linked to heart size or blood pressure. Am. J. Cardiol., 82(8):979-981.

[18]Qin, Y., Shi, G.P., 2011. Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases. Pharmacol. Ther., 131(3):338-350.

[19]Roselaar, S.E., Kakkanathu, P.X., Daugherty, A., 1996. Lymphocyte populations in atherosclerotic lesions of apoE –/– and LDL receptor –/– mice. Decreasing density with disease progression. Arterioscler. Thromb. Vasc. Biol., 16(8):1013-1018.

[20]Schwartz, L.B., Austen, K.F., 1980. Enzymes of the mast cell granule. J. Invest. Dermatol., 74(5):349-353.

[21]Sharma, S., Rajan, U.M., Kumar, A., Soni, A., Ghosh, B., 2005. A novel (TG)n(GA)m repeat polymorphism 254 bp downstream of the mast cell chymase (CMA1) gene is associated with atopic asthma and total serum IgE levels. J. Hum. Genet., 50(6):276-282.

[22]Sun, J., Sukhova, G.K., Wolters, P.J., Yang, M., Kitamoto, S., Libby, P., MacFarlane, L.A., Mallen-St Clair, J., Shi, G.P., 2007. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat. Med., 13(6):719-724.

[23]Szczeklik, A., Nizankowski, R., Mruk, J., 1977. Myocardial infarction in status asthmaticus. Lancet, 1(8012):658-659.

[24]Szczeklik, A., Milner, P.C., Birch, J., Watkins, J., Martin, J.F., 1986. Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. Thromb. Haemost., 56(3):283-287.

[25]Szczeklik, A., Sladek, K., Szczerba, A., Dropinski, J., 1988. Serum immunoglobulin E response to myocardial infarction. Circulation, 77(6):1245-1249.

[26]Szczeklik, A., Dropinski, J., Gora, P.F., 1993. Serum immunoglobulin E and sudden cardiac arrest during myocardial infarction. Coron. Artery Dis., 4(11):1029-1032.

[27]Tunon de Lara, J.M., Okayama, Y., McEuen, A.R., Heusser, C.H., Church, M.K., Walls, A.F., 1994. Release and inactivation of interleukin-4 by mast cells. Ann. N. Y. Acad. Sci., 725:50-58.

[28]Urata, H., Kinoshita, A., Perez, D.M., Misono, K.S., Bumpus, F.M., Graham, R.M., Husain, A., 1991. Cloning of the gene and cDNA for human heart chymase. J. Biol. Chem., 266(26):17173-17179.

[29]Vercelli, D., 2008. Discovering susceptibility genes for asthma and allergy. Nat. Rev. Immunol., 8(3):169-182.

[30]Wu, G.R., Ma, A.Q., Li, Z.H., Geng, T., 2002. Study of the association of the I/D polymorphism of the ACE gene, A/G polymorphism of the heart chymase gene and idiopathetic dilated cardiomyopathy. J. Clin. Cardiol., 18(3):100-103 (in Chinese).

[31]Xiang, M., Sun, J., Lin, Y., Zhang, J., Chen, H., Yang, D., Wang, J., Shi, G.P., 2011. Usefulness of serum tryptase level as an independent biomarker for coronary plaque instability in a Chinese population. Atherosclerosis, 215(2):494-499.

[32]Xu, J., Postma, D.S., Howard, T.D., Koppelman, G.H., Zheng, S.L., Stine, O.C., Bleecker, E.R., Meyers, D.A., 2000. Major genes regulating total serum immunoglobulin E levels in families with asthma. Am. J. Hum. Genet., 67(5):1163-1173.

[33]Ying, S.Q., Xiang, M.X., Fang, L., Wang, J.A., 2010. Temporal changes in circulating P-selectin, plasminogen activator inhibitor-1, magnesium, and creatine kinase after percutaneous coronary intervention. J. Zhejiang Univ.-Sci. B, 11(8):575-582.

[34]Yoshikawa, T., Imada, T., Nakakubo, H., Nakamura, N., Naito, K., 2001. Rat mast cell protease-I enhances immunoglobulin E production by mouse B cells stimulated with interleukin-4. Immunology, 104(3):333-340.

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2022 Journal of Zhejiang University-SCIENCE